#USA #Himed #Old Bethpage #Adva Cera #bioceramics

Himed and Adva Cera Join Forces to Revolutionize Bioceramic Medical Devices

In a landmark collaboration, Himed, a frontrunner in the production of bioceramic materials, has teamed up with Adva Cera, renowned for its expertise in advanced ceramic additive manufacturing. This partnership is set to innovate the development pathway of 3D-printed calcium phosphate (CaP) components, which are critical to dental, orthopedic, and spinal applications. The duo aims to provide clients with a streamlined and efficient transition from design to full-scale production, removing significant barriers traditionally associated with manufacturing medical devices.

Himed has a rich history stretching back to 1991, establishing itself as a pioneer in bioceramics characterization. With an all-inclusive research and production facility situated in Old Bethpage, New York, Himed offers a diverse range of raw calcium phosphate biomaterials suitable for multiple applications. Its recent establishment of the Bioceramics Center of Excellence™ (BCoE) has positioned the company as a critical player in advancing 3D-printed bioceramic technologies. The BCoE not only facilitates med tech startups but also assists established manufacturers by leveraging Himed's 35 years of materials expertise to perfect their designs before committing to large-scale production.

Adva Cera, previously operating under the name SiNAPTIC Technologies, stands out as a service bureau focused on the additive manufacturing of technical ceramic components. Based in Broomfield, Colorado, the company is known for its ability to create high-performance ceramic parts that are not achievable through conventional manufacturing methods. The integration of Adva Cera's advanced facilities into the Himed production process ensures that clients can smoothly navigate from prototype development to qualified production runs, without the need for requalification or capital investments in new infrastructure.

The significance of this partnership lies not only in its innovative approach to bioceramics but also in the regulatory assurances offered to customers. Now, users of the Bioceramics Center of Excellence can count on a well-defined production pathway, affording them the confidence to transition their fully optimized 3D-printed implant designs into a scalable manufacturing process that adheres to strict regulatory standards.

Craig Rosenblum, President of Himed, notes, "Customers who approach us now have a clear transition from design to production. This partnership with Adva Cera highlights the strengths of both companies and facilitates a smoother journey for our clients, enabling them to deliver next-generation implants to patients effectively."

Additionally, this collaboration ensures that the production framework is entirely domestic and vertically integrated, a feature increasingly valued by original equipment manufacturers (OEMs) eager to minimize their reliance on overseas manufacturing for additive processes. Hugh Roberts, President of Adva Cera, expressed enthusiasm regarding the partnership, stating, “Himed has created something immensely valuable for the medtech industry. We look forward to playing our role as the scale partner in this endeavor.”

The technology showcased at this partnership includes bioceramic implants, which have gained traction in orthopedics and dentistry due to their unique capability to bond with surrounding tissues. Unlike inert metals and polymers, calcium phosphate—being the mineral phase of bone—facilitates a natural connection with the body’s anatomy. The evolution of ceramic additive manufacturing has now enabled the production of intricate shapes with controlled porosity, thus addressing the growing market demands for customized medical solutions.

Market insights reveal that the ceramics 3D printing sector is on track to approach $900 million by 2033, reflecting a rapid rise in the adoption of these technologies. However, the transition from a prototyped idea to a commercially viable production service has remained a complex challenge for many enterprises. The Himed-Adva Cera partnership aims to eliminate these hurdles, creating a clear and effective bridge between innovation and practical implementation.

Both companies are set to demonstrate their collaborative efforts at the upcoming Orthopaedic Manufacturing Technology Exhibition & Conference (OMTEC) in Chicago from June 9 to 11, where they will share insights and showcase advancements in the realm of bioceramics.

This partnership not only announces a new era in bioceramic production but also stands as a testament to the potential for innovation and growth within the medical device industry. As Himed and Adva Cera continue to push the boundaries of what is possible in medical manufacturing, they solidify their roles as key players in advancing technology that prioritizes patient care and safety.